Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease

Por Kieler, Markus, Scheithauer, Werner, Zielinski, Christoph C, Chott, Andreas, Al-Mukhtar, Ali, Prager, Gerald W
Publicado no ESMO Open (2016)

Checkpoint inhibitors in the treatment of urological malignancies

Por Popovic, Lazar S, Matovina-Brko, Gorana, Popovic, Maja
Publicado no ESMO Open (2017)

Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature

Por Kastrisiou, Myrto, Kostadima, Fereniki-Lida, Kefas, Aristides, Zarkavelis, George, Kapodistrias, Nikos, Ntouvelis, Evangelos, Petrakis, Dimitrios, Papadaki, Alexandra, Vassou, Amalia, Pentheroudakis, George
Publicado no ESMO Open (2017)

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury

Por Doherty, Gary Joseph, Duckworth, Adam M, Davies, Susan E, Mells, George F, Brais, Rebecca, Harden, Susan V, Parkinson, Christine A, Corrie, Pippa G
Publicado no ESMO Open (2017)

Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma

Por Chamadol, Nittaya, Laopaiboon, Vallop, Srinakarin, Jiraporn, Loilome, Watcharin, Yongvanit, Puangrat, Thinkhamrop, Bandit, Khuntikeo, Narong
Publicado no ESMO Open (2017)

Management of recurrent or metastatic thyroid cancer

Por Tahara, Makoto
Publicado no ESMO Open (2018)

Choosing wisely in oncology: necessity and obstacles

Por Saletti, Piercarlo, Sanna, Piero, Gabutti, Luca, Ghielmini, Michele
Publicado no ESMO Open (2018)

Survey of the management of chemotherapy-induced peripheral neuropathy in Japan: Japanese Society of Medical Oncology

Por Hirayama, Yasuo, Sasaki, Jiichiro, Dosaka-Akita, Hirotoshi, Ishitani, Kunihiko
Publicado no ESMO Open (2016)

Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015

Por Rolfo, Christian, Caglevic, Christian, Bretel, Denisse, Hong, David, Raez, Luis E, Cardona, Andres F, Oton, Ana B, Gomez, Henry, Dafni, Urania, Vallejos, Carlos, Zielinski, Christoph
Publicado no ESMO Open (2016)

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer

Por Granier, Clemence, De Guillebon, Eleonore, Blanc, Charlotte, Roussel, Helene, Badoual, Cecile, Colin, Elia, Saldmann, Antonin, Gey, Alain, Oudard, Stephane, Tartour, Eric
Publicado no ESMO Open (2017)

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment

Por Saraiva, Diana P, Guadalupe Cabral, M, Jacinto, António, Braga, Sofia
Publicado no ESMO Open (2017)

Targeting immune checkpoints in breast cancer: an update of early results

Por Solinas, Cinzia, Gombos, Andrea, Latifyan, Sofiya, Piccart-Gebhart, Martine, Kok, Marleen, Buisseret, Laurence
Publicado no ESMO Open (2017)

Biology of premature ageing in survivors of cancer

Por Cupit-Link, Margaret C, Kirkland, James L, Ness, Kirsten K, Armstrong, Gregory T, Tchkonia, Tamar, LeBrasseur, Nathan K, Armenian, Saro H, Ruddy, Kathryn J, Hashmi, Shahrukh K
Publicado no ESMO Open (2017)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer

Por Morgillo, Floriana, Della Corte, Carminia Maria, Fasano, Morena, Ciardiello, Fortunato
Publicado no ESMO Open (2016)

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, a...

Por Shibata, H, Kato, S, Sekine, I, Abe, K, Araki, N, Iguchi, H, Izumi, T, Inaba, Y, Osaka, I, Kato, S, Kawai, A, Kinuya, S, Kodaira, M, Kobayashi, E, Kobayashi, T, Sato, J, Shinohara, N, Takahashi, S, Takamatsu, Y, Takayama, K, Takayama, K, Tateishi, U, Nagakura, H, Hosaka, M, Morioka, H, Moriya, T, Yuasa, T, Yurikusa, T, Yomiya, K, Yoshida, M
Publicado no ESMO Open (2016)

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls

Por Horak, Peter, Fröhling, Stefan, Glimm, Hanno
Publicado no ESMO Open (2016)

Retrospective analysis of HER2 therapy interruption in patients responding to the treatment in metastatic HER2+ breast cancer

Por Moilanen, Tiina, Mustanoja, Susanna, Karihtala, Peeter, Koivunen, Jussi P
Publicado no ESMO Open (2017)

Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma

Por Lu, Jian, Guo, Jin-He, Zhu, Hai-Dong, Zhu, Guang-Yu, Wang, Yong, Zhang, Qi, Chen, Li, Wang, Chao, Pan, Tian-Fan, Teng, Gao-Jun
Publicado no ESMO Open (2017)

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

Por Siravegna, Giulia, Geuna, Elena, Mussolin, Benedetta, Crisafulli, Giovanni, Bartolini, Alice, Galizia, Danilo, Casorzo, Laura, Sarotto, Ivana, Scaltriti, Maurizio, Sapino, Anna, Bardelli, Alberto, Montemurro, Filippo
Publicado no ESMO Open (2017)

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients

Por Negrouk, Anastassia, Lacombe, Denis, Cardoso, Fatima, Morin, Franck, Carrasco, Eva, Maurel, Joan, Maibach, Rudolf, Aranda, Enrique, Marais, Richard, Stahel, Rolf A
Publicado no ESMO Open (2017)